Mainstream

Revelation Biosciences To Effect 1 For 16 Reverse Stock Split To Regain Nasdaq Compliance

Revelation Biosciences to effect 1-for-16 reverse stock split to regain Nasdaq compliance

Revelation Biosciences to effect 1-for-16 reverse stock split to regain Nasdaq compliance

Post ContentrevbRead More

You might also be interested in reading Plains GP signals 3% EBITDA growth for 2025 with expanded asset base.

January 24, 2025
In Mainstream